Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : investor guidance

Medtronic Q3 FY26 Earnings: Revenue Up 8.7%, Strong Growth in Cardiac and Diabetes Segments

Medtronic Q3 FY26 Earnings: Revenue Up 8.7%, Strong Growth in Cardiac and Diabetes Segments
02/17/2026 | Companies
Medtronic plc, a leading global healthcare technology company, announced its financial performance for the third quarter (Q3) of fiscal year 2026, which concluded on January 23, 2026. Q3 Highlights Revenue reached $9.0 billion, reflecting an 8.7% reported increase and 6.0% organic growth,...
Anteris, cardiac ablation, cardiovascular portfolio, CathWorks, CE Mark, diabetes business, earnings outlook, earnings report, FDA clearance, financial performance, FY26 Q3 results, GAAP EPS, healthcare technology, Hugo robotic surgery, innovation pipeline, investor guidance, medical devices, medical surgical portfolio, Medtronic, mergers and acquisitions, neuroscience portfolio, non-GAAP EPS, organic growth, pulsed field ablation, revenue growth, Stealth AXiS, webcast

How Investor Engagement Can Improve Water Security and Drive Sustainable Value

How Investor Engagement Can Improve Water Security and Drive Sustainable Value
06/16/2025 | Companies
What You Need to Know Water security poses a significant challenge across the globe — requiring a way to manage the growing pressures stemming from scarcity, excess, and contamination. In this paper, we propose a fresh approach to navigating water-related risks, with a view toward delivering more...
beverage industry, community engagement, corporate responsibility, financial performance, investor framework, investor guidance, metals and mining, semiconductor manufacturing, stakeholder engagement, sustainable investing, water risk, water security


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com